XML 24 R12.htm IDEA: XBRL DOCUMENT v3.22.0.1
Balance Sheet Components
12 Months Ended
Dec. 31, 2021
Balance Sheet Components [Abstract]  
Balance Sheet Components

Note 5: Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Prepaid expenses

 

$

333

 

 

$

274

 

Prepaid insurance

 

 

1,144

 

 

 

964

 

Prepaid research and development expenses

 

 

1,899

 

 

 

2,110

 

Australia research and development refundable tax credit

 

 

1,128

 

 

 

 

Other current assets

 

 

367

 

 

 

694

 

Total prepaid expenses and other current assets

 

$

4,871

 

 

$

4,042

 

 

Cortexyme Australia, Pty, Ltd, is eligible to obtain a cash refund from the Australian Taxation Office for eligible R&D expenditures under the Australian R&D Tax Incentive Program (the “Australian Tax Incentive”). The Australian Tax Incentive is recognized as a reduction to R&D expense when there is reasonable assurance that the relevant expenditure has been incurred, the amount can be reliably measured and that the Australian Tax Incentive will be received. The Company recognized reductions to R&D expense of $1.1 million, $0 million, and $0 million for the years ended December 31, 2021, 2020, and 2019 respectively.

 

Property and equipment, net

Property and equipment, net consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Computer equipment

 

$

53

 

 

$

33

 

Lab equipment

 

 

528

 

 

 

405

 

Finance lease right of use assets

 

 

557

 

 

 

557

 

Leasehold improvement

 

 

58

 

 

 

21

 

Office furniture

 

 

26

 

 

 

26

 

Less: accumulated amortization and depreciation

 

 

(959

)

 

 

(615

)

Property and equipment, net

 

$

263

 

 

$

427

 

 

Depreciation expense for property and equipment was $344,000, $332,000 and $188,000 for the years ended December 31, 2021, 2020, and 2019, respectively.

Accrued Expenses and Other Current Liabilities

Accrued expense and other current liabilities consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Personnel expenses

 

$

820

 

 

$

2,415

 

Professional fees

 

 

462

 

 

 

141

 

Research and development expenses

 

 

7,108

 

 

 

10,603

 

Current portion of operating lease liabilities

 

 

741

 

 

 

238

 

Other

 

 

180

 

 

 

44

 

Total accrued expenses and other current liabilities

 

$

9,311

 

 

$

13,441